
A leading pro-life group said it opposed advancing Heidi Overton's nomination to lead the Food and Drug Administration without commitments from the Trump administration on abortion drug policy.
The White House withdrew her nomination this week amid questions about her support in the Senate.
In an interview with Fox News Digital, Erik Baptist, senior vice president of legal strategy at Susan B.
Anthony Pro-Life America, said his group asked the Senate to hold up Overton’s confirmation until it received "firm commitments" from the administration on two fronts regarding abortion drug policy.
Baptist said the group wants the next FDA nominee to commit to ending mail-order access to abortion drugs authorized under the Biden administration and changing how the agency studies the s…
المصدر: foxnews politics












